Medicare Enrolled
Dr. Liliana Bustamante, MD
Hematology · Cape Coral, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bustamante from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bustamante? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bustamante
Dr. Liliana Bustamante is a hematology in Cape Coral, FL, with 14 years in practice. Based on federal Medicare data, Dr. Bustamante performed 205,163 Medicare services across 4,895 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bustamante received a total of $34,073 from 79 pharmaceutical and/or device companies across 758 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bustamante is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice▲ Top 20% volume in FL$ $34,073 industry payments
Medicare Practice Summary
Medicare Utilization ↗205,163
Medicare services
Top 20% in FL for hematology
4,895
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~14,654 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 33,601 | $43 | $137 |
| Iron sucrose injection (Venofer) | 20,000 | $0 | $5 |
| Anti-nausea injection (aprepitant) | 19,110 | $1 | $5 |
| Oxaliplatin chemotherapy injection | 18,693 | $0 | $12 |
| Nivolumab injection (Opdivo) | 14,600 | $23 | $72 |
| Iron infusion (Feraheme) | 13,260 | $0 | $4 |
| Filgrastim injection (Zarxio) for white blood cells | 11,520 | $0 | $2 |
| Daratumumab injection (Darzalex) | 10,440 | $38 | $110 |
| Paclitaxel chemotherapy injection | 9,572 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 8,040 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia | 7,660 | $6 | $23 |
| Azacitidine chemotherapy injection | 6,570 | $0 | $4 |
| Dexamethasone injection (steroid) | 4,127 | $0 | $3 |
| Injection, romiplostim, 10 micrograms | 3,448 | $73 | $197 |
| Immune globulin infusion (Gammagard) | 3,288 | $36 | $108 |
| Complete blood count (CBC) with differential | 2,608 | $8 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,250 | $1 | $28 |
| Blood draw (venipuncture) | 2,111 | $8 | $9 |
| Injection, bortezomib, 0.1 mg | 1,470 | $5 | $113 |
| Injection, leucovorin calcium, per 50 mg | 1,370 | $3 | $12 |
| Injection, fulvestrant, 25 mg | 1,260 | $8 | $132 |
| Office visit, established patient (20-29 min) | 999 | $68 | $239 |
| Anti-nausea injection (ondansetron/Zofran) | 960 | $0 | $9 |
| Injection of additional new drug or substance into vein | 862 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 775 | $102 | $378 |
| Injection, fluorouracil, 500 mg | 741 | $2 | $7 |
| Drug injection, under skin or into muscle | 715 | $11 | $69 |
| Office visit, established patient (30-39 min) | 581 | $99 | $339 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 533 | $3 | $205 |
| Injection, carboplatin, 50 mg | 392 | $2 | $41 |
| Injection, diphenhydramine hcl, up to 50 mg | 266 | $1 | $3 |
| Injection, cisplatin, powder or solution, 10 mg | 263 | $2 | $13 |
| Administration of chemotherapy into vein, each additional hour | 255 | $22 | $79 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 247 | $49 | $189 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 230 | $23 | $84 |
| Infusion into a vein for hydration, each additional hour | 202 | $10 | $42 |
| Infusion, normal saline solution , 1000 cc | 186 | $2 | $7 |
| Injection, zoledronic acid, 1 mg | 179 | $7 | $69 |
| Administration of additional new drug or substance into vein, 1 hour or less | 169 | $52 | $178 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 145 | $26 | $89 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 143 | $1 | $6 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 133 | $18 | $59 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 131 | $55 | $206 |
| Infusion into a vein for hydration, 31-60 minutes | 116 | $25 | $156 |
| Automated urinalysis | 115 | $2 | $8 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 106 | $16 | $56 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 104 | $134 | $637 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 90 | $133 | $562 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 85 | $16 | $56 |
| New patient office visit (45-59 min) | 79 | $132 | $453 |
| Injection of drug or substance into vein | 75 | $29 | $156 |
| New patient office visit, complex (60-74 min) | 74 | $166 | $585 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 47 | $3 | $11 |
| Injection, magnesium sulfate, per 500 mg | 46 | $1 | $2 |
| Office visit, established patient, complex (40-54 min) | 45 | $140 | $474 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 24 | $1 | $7 |
| Red blood count automated, with additional calculations | 20 | $5 | $20 |
| Red blood count, automated test | 16 | $4 | $10 |
| Hospital follow-up visit, moderate complexity | 16 | $65 | $197 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.7% high complexity
87.9% medium
3.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$34,073
Total received (2018-2024)
Avg $4,868/year across 7 years
Top 14% in FL for hematology
79
Companies
758
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15,777 (46.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,668 (40.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,628 (13.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$7,033
2023$15,847
2022$1,717
2021$4,073
2020$1,128
2019$1,495
2018$2,781
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$14,476
Eli Lilly and Company
$1,875
Bayer HealthCare Pharmaceuticals Inc.
$1,873
G1 Therapeutics, Inc.
$1,520
E.R. Squibb & Sons, L.L.C.
$1,330
Bayer Healthcare Pharmaceuticals Inc.
$1,167
Janssen Biotech, Inc.
$1,055
Novartis Pharmaceuticals Corporation
$978
PFIZER INC.
$843
Merck Sharp & Dohme LLC
$744
Genentech USA, Inc.
$519
Incyte Corporation
$496
Merck Sharp & Dohme Corporation
$468
Celgene Corporation
$449
Seagen Inc.
$414
Gilead Sciences, Inc.
$391
Astellas Pharma US Inc
$384
AstraZeneca Pharmaceuticals LP
$310
GlaxoSmithKline, LLC.
$272
Exelixis Inc.
$269
BeiGene USA, Inc.
$261
Daiichi Sankyo Inc.
$236
NanoString Technologies, Inc.
$232
GENZYME CORPORATION
$221
Mirati Therapeutics, Inc.
$218
Lilly USA, LLC
$212
Agios Pharmaceuticals, Inc.
$206
Eisai Inc.
$205
ARRAY BIOPHARMA INC
$197
TAIHO ONCOLOGY, INC.
$197
JAZZ PHARMACEUTICALS INC.
$190
CTI BioPharma Corp.
$140
Sirtex Medical Inc
$113
Foundation Medicine, Inc.
$110
PORTOLA PHARMACEUTICALS, INC.
$97
ACELL, INC.
$94
AbbVie, Inc.
$88
Takeda Pharmaceuticals U.S.A., Inc.
$88
ABBVIE INC.
$83
TerSera Therapeutics LLC
$79
Intera Oncology, Inc
$69
AbbVie Inc.
$49
EMD Serono, Inc.
$46
Pharmacyclics LLC, An AbbVie Company
$44
Merz North America, Inc.
$41
GE HEALTHCARE
$40
Puma Biotechnology, Inc.
$38
Deciphera Pharmaceuticals Inc.
$36
MERZ NORTH AMERICA, INC.
$35
MorphoSys, US Inc.
$32
ImmunoGen, Inc.
$32
SOBI, INC
$30
INSYS Therapeutics Inc
$28
Sumitomo Pharma America, Inc.
$27
SpringWorks Therapeutics, Inc.
$25
Heron Therapeutics, Inc.
$25
Legend Biotech USA Inc.
$24
Pharmacyclics LLC, an AbbVie Company
$23
Adaptive Biotechnologies Corporation
$22
Pharmacosmos Therapeutics Inc.
$21
Alnylam Pharmaceuticals Inc.
$20
CSL Behring
$20
Seattle Genetics, Inc.
$19
Verastem, Inc.
$18
Jazz Pharmaceuticals Inc.
$18
AVEO Pharmaceuticals, Inc.
$18
Genmab U.S., Inc.
$17
Spectrum Pharmaceuticals Inc.
$15
Otsuka America Pharmaceutical, Inc.
$15
R-Pharm US LLC
$15
Aurobindo Pharma USA, Inc.
$15
PUMA BIOTECHNOLOGY, INC.
$14
PharmaEssentia USA Corporation
$14
Taiho Oncology, Inc.
$13
Octapharma USA, Inc.
$12
Horizon Pharma plc
$12
Myovant Sciences Inc.
$11
Dendreon Pharmaceuticals LLC
$11
Veracyte, Inc.
$4
Top 3 companies account for 53.5% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BESREMI · BEVYXXA · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CEREZYME · CINVANTI · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Elahere · Enhertu · Epkinly · Erleada · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAUCHER-DISEASE · GAZYVA · HEMGENIX · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INTERA · Ixempra · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MYLOTARG · Morphabond ER · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROSIGNA ASSAY · PROVENGE · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETACRIT · RETEVMO · RYBREVANT · RYDAPT · Revlimid · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SPRYCEL · SUTENT · SYNDROS · Stivarga · TAFINLAR · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Trodelvy · VARUBI · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vonjo · Vyloy · XALKORI · XTANDI · Xeomin · Xospata · Xtandi · ZEJULA · ZEPZELCA · ZOLADEX · Zevalin · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (46%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology and does not inherently indicate bias, but patients may wish to be aware.
Equivalent to $17 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
13
Per 100K population
1.6
County median income
$73,099
Nearest hospital
CAPE CORAL HOSPITAL
6.4 mi
6.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bustamante is a mixed practice specialist, with above-average Medicare volume (top 20% in FL), and high industry engagement (speaking/promotional, top 14%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bustamante experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Bustamante performed 33,601 pembrolizumab injection (keytruda) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bustamante receive payments from pharmaceutical companies?
Yes. Dr. Bustamante received a total of $34,073 from 79 companies across 758 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bustamante's costs compare to other hematologys in Cape Coral?
Dr. Bustamante's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bustamante) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Cape Coral
Browse hematologys in Cape Coral ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
Eli Lilly and Company Payments to Doctors
See all physicians who received payments from Eli Lilly and Company.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology